
Loan Licence Manufacturing: The clients provide the necessary raw materials, guidance, supporting documents and formulations, following which they make their products. Low margin segment due to fixed fee per batch — the client captures the upside margin.
Contract Manufacturing: The company procures its own raw materials, manufactures finished products, and supplies them to clients who market these under their own brands. Higher margins through merchant exports but lower pricing power.
Direct Export/Own Brand Manufacturing: Alongside its B2B focus, Curis has also begun building an export-led branded business by marketing its own formulations in select overseas markets such as Yemen and Kenya. High margin segment in semi-regulated markets.
Capital Expenditure towards Upgradation/Improvement of our existing Manufacturing Facilities
Capital Expenditure towards Construction of a Storage Facility
Pre-payment/Repayment of outstanding Secured Loans
Product Registrations in other countries
Funding our Working Capital Requirements
General Corporate Purpose
WHO-GMP certified facility with capacity across tablets, capsules, liquids, ointments, and sterile formulations.
Reduced debt in the company by bringing down D/E from 16x to 0.8x recently.
Expansion through capex expansion and product registrations in more countries with the upcoming IPO.
No direct marketing or R&D burden; focuses purely on manufacturing efficiency.
Large installed capacity with scope to double output once utilization improves.
Top 5 customers contribute >90% of revenue; dependency risk high.
Current utilization below 50% — idle assets dilute operating leverage.
Focus on low-differentiation generics limits pricing power and margins.
Absence of USFDA/EU-GMP certifications restricts access to high-value regulated markets.
Sustained negative cash flows in key areas could hinder growth and financial stability.
Execution risk around successful product registrations and export expansion.
0
28
0
Share On
Table Of Content
Company Overview
Revenue and Product Mix
IPO Objectives
Company Strengths and Risks
Tags
SME IPO
SME IPO review